| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.93M | - | |
| Dir | 164.0K | $12.56M | -8,000 | |
| VP | 100.3K | $7.68M | - | |
| VP | 83.3K | $6.38M | -60,846 | |
| CFO | 82.7K | $6.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2021 | Berthelsen Spencer R | Director | Sale+OE | 15,000 | $37.74 | $566,100.00 | -12.9% | -4.0% | +3.3% | |
| Jun 15, 2021 | Muto Frederick T | Director | Sale+OE | 15,000 | $36.63 | $549,500.00 | -13.6% | -1.1% | -5.5% | |
| Mar 1, 2021 | Monia Brett P60 | Chief Executive Officer | Sell | 236 | $54.28 | $12,808.90 | -0.5% | - | - | |
| Jan 26, 2021 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 28,333 | $63.74 | $1,805,812.25 | -93.3% | - | - | |
| Jan 25, 2021 | O'Neil Patrick R.57 | EVP &General Counsel | Sell | 5,324 | $63.50 | $338,074.00 | -16.7% | - | - | |
| Jan 22, 2021 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 75,000 | $61.45 | $4,609,117.04 | -4.5% | - | - | |
| Jan 13, 2021 | Geary Richard S65 | EVP, Chief Development Offc | Sell | 141 | $59.50 | $8,389.50 | -0.5% | - | - | |
| Jan 5, 2021 | Swayze Eric63 | EVP, Research | Sell | 195 | $55.99 | $10,918.05 | -3.7% | - | - | |
| Dec 23, 2020 | Parshall B Lynne74 | Director | Sell | 10,000 | $60.00 | $600,000.00 | -14.8% | - | - | |
| Dec 17, 2020 | Crooke Stanley T | Exec Chairman Of The Board | Sell | 40,407 | $49.80 | $2,012,278.50 | -6.3% | - | - |